White paper | Medications: When cost-cutting proves costly

Did you know? The prescription drug insurance plans that are the most cost-effective on paper aren’t always the ones that provide the most value.

The fact is, costs alone are not enough to accurately assess the true value of a plan. That is why our white paper challenges a management approach focused solely on controlling costs.

Instead, we propose taking into account health outcomes, costs avoided and benefits for individuals and organizations to better control costs without compromising the value of the plan.